Media Room
Welcome to our Media Room.
This page is intended for media-related inquiries and we will be happy to assist and provide current and historical news as well as new developments.
Latest News
Contact
Jerusalem, Israel, May 6, 2008
TEVA REPORTS FIRST QUARTER 2008 RESULTS
Jerusalem, Israel, April 30, 2008
Teva Announces Global In-Market First Quarter Sales Of Copaxone® Increased 35% To $542 Million
Jerusalem, Israel, April 28, 2008
Teva Announces Approval Of Generic Flolan® For Injection
Ayala Miller
Director, Corporate Communications
Teva Pharmaceutical Industries Ltd.
Tel: +972-3-9267590
Fax: +972-3-9237862
ayala.miller@teva.co.il
Denise Bradley
Director, Communications & Community
Relations
Teva North America.
Tel: +1-215-5918974
denise.bradley@tevausa.com
More News...
Back to Top
Legal Note
|
Site Map
Copyright © 1999 - 2008 Teva. All rights reserved